Companies in the News: Frutarom, Fonterra, Cyanotech, Nutraceutical International, Lonza, Chr. Hanson, International Flavors & Fragrances, AXM Pharma, China Zuellig Xin Xing, American Capital Strategies, Seroyal International, Seroyal USA, Reliv International, Martek Biosciences, NBTY, Global Health Trax, Amway, Bravo! Foods, Mueggenburg, Advanced Nutraceuticals, Raisio, Valio, Advanced BioNutrition, SAM Equity Partners, BASF Venture Capital, Arancia Industrial SA de CV, Sherbrooke Capital, Eastbourne Capital Management, CV Technologies, Weider Nutrition, Cognis, SVG Capital, EYI Industries, Efficas, Bay Area Equity Fund, Boston Life Science Venture Corp., Hovid Bhd, Carotech Bhd.
1/31/2005 - Frutarom's London Issue Likely This Week
According to an article in Haaretz, Israel-based Frutarom Industries Ltd. (TASE: FRUT), a subsidiary of subsidiary of US-based ICC Industries Inc., will be floating stock this week in London. According to the article, about 7 million shares will b offered, expected to garner the organization about $100 million.
1/28/2005 - Fonterra Revenues Rise in First Half
New Zealand Dairy company Fonterra has announced six month operating revenues of $5.7 billion, a 2% increase over previous year results.
1/28/2005 - Cyanotech Corporation Reports Third Quarter Fiscal 2005 Financial Results
US-based natural products company Cyanotech Corporation (Nasdaq:CYAN) has announced FY05 Q3 results, reporting net income of $326,000, or $0.02 per diluted share, on sales of $3,180,000, compared to net income of $109,000, or $0.01 per diluted share on sales of $3,000,000 the previous year.
1/27/2005 - Nutraceutical Reports Sales and Income
US-based supplement company Nutraceutical International Corporation (Nasdaq: NUTR) has reported FY05 q1 results, with sales of $35.3 million compared to $33.2 million previous year, with net income at $2.8 million, or $0.24 diluted earnings per share, compared to $3.2 million, or $0.27 diluted earnings per share prior year.
1/26/2005 - Lonza Announces 2004 Results
Switzerland-based Lonza has announced FY04 results, with group operating income (before special items and amortization of goodwill) decreasing 28.8% to CHF 215 million, while net income increased by 51.6% to CHF 138 million. Net sales declined 2.7% and operating margins decreased from 13.5% to 9.9%.
1/26/2005 - Chr. Hansen Announces First Quarter Results
Denmark-based Chr. Hansen A/S has announced FY05 Q1 results, noting a 4% increase in revenues in local currencies. Sales for Q1 were reported as DKK 845 million (approximately USD 149 million), up from DKK 836 million prior year, but the company reported that organic sales growth fell in the US while gaining in Canada and Mexico.
1/26/2005 - IFF Reports Fourth Quarter and Full Year Sales and Earnings
US-based International Flavors & Fragrances (NYSE:IFF) has announced FY04 and Q4 results, reporting Company reports Q4 sales of $468.2 million, declining 1% in comparison to the prior year quarter, impacted by disposition of the Company's European fruit preparations businesses, which were sold to Frutarom Industries Ltd. The company reported earnings per share for FY04 Q4 of $.43 compared to $.40 for the prior year, which, excluding special charges, would have been $.46 compared to $.48 the previous year.
Link 1: http://www.npicenter.com/anm/templates/newsATemp.aspx?articleid=11539&zoneid=12
1/25/2005 - AXM Pharma Receives Chinese Approval to Begin Selling Sunkist Line
AXM Pharma, Inc. (AXJ) has announced that it has received GMP approval by the Chinese State Food and Drug Administration, and can begin selling the Sunkist brand of products in China through a distribution agreement with China Zuellig Xin Xing. According to the company, the first products to be launched are Sunkist dissolve-in-the-mouth films and Chew Chew Gummy Bear vitamin products including Vitamin C, zinc lozenge, Echinacea, and other nutraceutical products.
1/24/2005 - American Capital Invests $20 Million in Seroyal International Inc. and Seroyal USA Inc.
US-based buyout and mezzanine fund company American Capital Strategies Ltd. (ACAS) has announced a December 2004 investment in US-based supplement company Seroyal International Inc. and Seroyal USA Inc. According to the company, the investment was in the form of a senior term loan B, senior subordinated debt and preferred and common equity and to support recapitalization.
1/24/2005 - Reliv Board Authorizes Plans to Enter German Market
US-based network marketer Reliv International, Inc. has announced that the company's Board of Directors has authorized expansion of Reliv's network marketing operations to Germany and surrounding countries in Europe.
1/24/2005 - Martek Biosciences Announces Pricing of Common Stock Offering
US-based Martek Biosciences Corporation has announced the offering of 1,527,490 shares of common stock at a public offering price of $49.10 per share. According to the company, the stock is expected to be issued January 26th, with proceeds to be used for capital expenditures, working capital and general corporate purposes.
1/21/2005 - NBTY Reports First Quarter Results
US-based supplement company NBTY, Inc. (NTY) has announced FY05 Q1 results, with sales of $420 million, compared to $385 million prior year, and net income of $30 million, or $0.43 per diluted share versus $24 million, or $0.34 per diluted share, for FY04 Q1. Net sales for the US Nutrition wholesale division were unchanged at $180 million, as were Vitamin World sales at $53 million, with same store sales decreasing 2 percent.
1/21/2005 - Global Health Trax Inc. Certified to Open Branch Office in Japan
US-based multilevel health and wellness company, Global Health Trax Inc. has announced that it has been certified by the Japanese government to open a branch office in Saitama, Japan. According to the company, the office will be over 4,000 square feet in size and employ a staff of 12.
1/20/2005 - Amway Eyes Expansion Prospects in China
According to an article in China Daily, direct-selling company Amway is set to expand Chinese production capacity to $3 billion, as that country's direct-selling industry reopens. According to the article, the current production capacity is $1.93 billion, and the company is hoping for up to 50% annual growth, led by its Nutrilite brand (which accounts for more than half of sales), and Artistry brand skincare and cosmetics products (currently less than 20% of sales).
1/20/2005 - Bravo! Foods Launches Canadian Division
US-based dairy products company Bravo! Foods International Corp. (OTC Bulletin Board: BRVO) has announced that it is launching a new Canadian division to be headed by Jeffrey Pencer, formerly National Sales Manager at Cotts Beverage.
1/19/2005 - Mueggenburg Targets North American Markets
Mueggenburg North America has announced that it is targeting the North American Health, Dietary supplement, Beverage, Tea, Flavor, Food, Liqueur, Perfume and Cosmetic, and Technical industries from offices in Florida and New Jersey.
1/17/2005 - Advanced Nutraceuticals, Inc. Announces Year End Results
US-based Advanced Nutraceuticals, Inc. (ANII), has announced Fy04 results with sales of $17.6 million compared to $12.8 million prior year, and net income from continuing operations of $4.2 million, ($.84 per common share ($.74 diluted)), compared with net income of $1.9 million, ($.39 per common share ($.38 diluted)) for FY 2003.
1/14/2005 - Raisio Invests in New Production Technology
Finland-based Raisio Group PLC has announced it will start production of oat- and soy-based fresh foods in Turku, Finland, using a facility the company has rented from Valio. According to the company, production and packaging technology investments required will be approximately 5 million euros, and the plant is expected to employ 15020 people with new products on the market in 2006.
1/13/2005 - SunOpta Inc. Announces Aseptic Plant Expansion
Canada-based natural and organic company SunOpta Inc. (STKL)(CA:SOY) has announced the opening of a new 45,000 square foot office and warehouse adjoining its aseptic plant in Alexandria, Minnesota.
1/13/2005 - Advanced BioNutrition Secures $7.5M in Private Financing
US-based health and wellness company, Advanced BioNutrition Corp., has raised $7.5 million in second round of private equity financing (led by SAM Equity Partners Ltd. and BASF Venture Capital GmbH, Arancia Industrial SA de CV, as well as ABN's Series A round investors, Sherbrooke Capital, Eastbourne Capital Management L.L.C., the Maryland Dept. of Business and Economic Development, and a private investor), and will use the proceeds to expand applications for its new MicroMatrix ingredient delivery technology, continue development of new disease prevention products, and to build sales of its DHA and ARA nutritional products.
1/11/2005 - CV Technologies Posts Record Sales of $11.3 Million in First Three Months of 2005
Canada-based natural products company CV Technologies Inc. (TSX VENTURE:CVQ) has reported FY05 Q1 results with gross sales of $11.3 million, compared to $1.76 million in sales for the same quarter prior year. The company has also reported a net profit of $150,918 for FY04, attributing the profitability to sales growth from $1,543,326 in 2003 to $6,416,732 in 2004.
1/11/2005 - Weider Announces Fiscal 2005 Second Quarter Results
US-based supplement and sports nutrition company Weider Nutrition International, Inc. (WNI) has reported FY05 Q2 results, with net sales of $67.0 million compared to $60.8 million prior year, and net income of $3.5 million ($0.13 per share) versus $2.7 million ($0.10 per share) for the same quarter, previous year.
1/10/2005 - Recapitalisation of Cognis
According to a release on UK-Wire, SVG Capital has been advised of the recapitalization of Cognis, returning 100% of the original cost of the investment to investors. In total, SVG Capital expects to receive approximately £49.9 million, in two recapitalizations - one in May 2004 as well as the current one, representing a multiple of 1.6x total investment cost.
1/7/2005 - EYI Industries Inc. Announces Move to New Facility
US-based supplement company EYI Industries Inc. (EYII) has announced it has moved to new leased facilities in the Vancouver lower mainland area of approximately 18,000 sq. ft. over 3 floors.
1/5/2005 - Efficas Raises $3 Million in Financing to Accelerate Development of Proprietary Bioactives
US-based natural bioactives focused biotech company Efficas Inc. has announced that it has secured $3 million in an A3 round of funding, bringing the current investment in Efficas to more than $8.5 million. According to the company, Bay Area Equity Fund, a San Francisco-based fund managed by J.P. Morgan, and Boston Life Science Venture Corp., the venture capital arm of the Industrial Bank of Taiwan, participated in the financing round.
1/4/2005 - Hovid, Carotech Expect to Float Shares By March
According to an article in Malaysia's The Star Online, Hovid Bhd and subsidiary Carotech Bhd, are expected to be listed on BursaMalaysia second board and Mesdaq market respectively by March. According to the article, the two are set to become the first companies from the same group seeking listing at the same time.